tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BPMC Stock Latest News

Blueprint Medicines price target raised to $115 from $110 at Morgan Stanley
The FlyBlueprint Medicines price target raised to $115 from $110 at Morgan Stanley
15d ago
BPMC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
LLY
BPMC
Blueprint Medicines price target raised to $125 from $114 at Oppenheimer
PremiumThe Fly
Blueprint Medicines price target raised to $125 from $114 at Oppenheimer
19d ago
BPMC
Blueprint Medicines management to meet with JMP Securities
PremiumThe Fly
Blueprint Medicines management to meet with JMP Securities
1M ago
BPMC
Blueprint Medicines management to meet with JMP Securities
PremiumThe Fly
Blueprint Medicines management to meet with JMP Securities
1M ago
BPMC
Blueprint Medicines Shareholders Endorse Key Proposals
PremiumCompany AnnouncementsBlueprint Medicines Shareholders Endorse Key Proposals
1M ago
8K
BPMC
Blueprint Medicines announces avapritinib presentations at EAACI/EHA meetings
PremiumThe Fly
Blueprint Medicines announces avapritinib presentations at EAACI/EHA meetings
2M ago
BPMC
Blueprint Medicines initiated with an Overweight at Stephens
PremiumThe Fly
Blueprint Medicines initiated with an Overweight at Stephens
2M ago
BPMC
Blueprint Medicines upgraded to Market Perform from Underperform at Leerink
PremiumThe Fly
Blueprint Medicines upgraded to Market Perform from Underperform at Leerink
3M ago
BPMC
Blueprint Medicines price target raised to $104 from $78 at Piper Sandler
PremiumThe Fly
Blueprint Medicines price target raised to $104 from $78 at Piper Sandler
3M ago
BPMC
Blueprint Medicines price target raised to $125 from $114 at JMP Securities
PremiumThe Fly
Blueprint Medicines price target raised to $125 from $114 at JMP Securities
3M ago
BPMC
Blueprint Medicines price target raised to $76 from $65 at Citi
PremiumThe Fly
Blueprint Medicines price target raised to $76 from $65 at Citi
3M ago
BPMC
Blueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
PremiumThe FlyBlueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
3M ago
BPMC
Blueprint Medicines price target raised to $75 from $70 at Barclays
PremiumThe Fly
Blueprint Medicines price target raised to $75 from $70 at Barclays
3M ago
BPMC
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
PremiumThe Fly
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
3M ago
BPMC
Blueprint Medicines sees FY24 AYVAKIT net product revenues $390M-$410M
PremiumThe Fly
Blueprint Medicines sees FY24 AYVAKIT net product revenues $390M-$410M
3M ago
BPMC
Blueprint Medicines reports Q1 EPS $1.40 vs. $($2.15) last year
PremiumThe Fly
Blueprint Medicines reports Q1 EPS $1.40 vs. $($2.15) last year
3M ago
BPMC
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
PremiumPress Releases
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
3M ago
BPMC
Blueprint Medicines price target raised to $130 from $120 at Stifel
PremiumThe Fly
Blueprint Medicines price target raised to $130 from $120 at Stifel
3M ago
BPMC
Cogent Biosciences price target raised to $13 from $11 at Citi
PremiumThe FlyCogent Biosciences price target raised to $13 from $11 at Citi
5M ago
BPMC
COGT
Blueprint Medicines announces PIONEER trial results
PremiumThe Fly
Blueprint Medicines announces PIONEER trial results
5M ago
BPMC
Blueprint Medicines Divests GAVRETO Rights to Rigel
PremiumCompany Announcements
Blueprint Medicines Divests GAVRETO Rights to Rigel
5M ago
8K
BPMC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >